AzTrials
AzTrials

Analgesia After Laparoscopic CholecystectomyNCT07750769

Opioid-Free Analgesia for Laparoscopic Cholecystectomy

A study testing EOI with OFA and OFA in people with Analgesia After Laparoscopic Cholecystectomy, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

laparoscopic cholecystectomy (LC) is often accompanied by moderate-to-severe postoperative pain. opioid-free anesthesia (OFA) consists of a variety of non-opioid narcotic drugs and techniques. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
EOI with OFA and OFA
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
70 participants
Where
No sites listed yet
Study dates
15 Oct 2026to 15 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients scheduled for elective laparoscopic cholecystectomy (LC) surgery under general anesthesia, American Society of Anesthesiologists (ASA) physical status I-II, aged from 18 to 65 years old of either sex

Who cannot join

  • Contraindications to regional block (coagulopathy, infection at the needle insertion site, or known allergy to amide local anesthetics)
  • Pregnancy or breastfeeding women
  • Body mass index (BMI) > 35 Kg/m2
  • History of hepatic, renal, or cardiac disease
  • Chronic opioid use, or history of chronic pain (pain present for more than 6 months)
  • Thoracic deformity
  • Neuropsychiatric disorders
  • Patient refusal.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Mohamed R Shaaban, Msc. contact

01140541916 ext. 02

mohamedrefaat@aun.edu.eg

About this study

Official title: Analgesic Efficacy of Opioid-Free Anesthesia Protocol Combined With Ultrasound-Guided External Oblique Intercostal Plane Block for Laparoscopic Cholecystectomy: A Prospective Randomized Comparative Study

laparoscopic cholecystectomy (LC) is often accompanied by moderate-to-severe postoperative pain. opioid-free anesthesia (OFA) consists of a variety of non-opioid narcotic drugs and techniques.

Read the detailed description

opioid-free anesthesia (OFA) can control postoperative pain effectively and reduce opioid drug consumption.

The external oblique intercostal plane (EOI) block is easy to perform and may provide effective analgesia for laparoscopic cholecystectomy.

Being tested
EOI with OFA, OFA

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EOI with OFAProcedure or surgery

    Patients will receive ultrasound-guided external oblique intercostal plane (EOI) block added to an opioid-free anesthesia (OFA) protocol

  • OFADrug

    Patients will receive an opioid-free anesthesia (OFA) protocol

Study groups in NCT07750769
Study groupRoleWhat they receive
Group IActive comparatorPatients will receive ultrasound-guided external oblique intercostal plane (EOI) block added to an opioid-free anesthesia (OFA) protocol
Receives: Procedure: EOI with OFA
Group IIPlacebo comparatorPatients will receive an opioid-free anesthesia (OFA) protocol
Receives: Drug: OFA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the amount of fentanyl consumption used for pain relief in the first six hours after laparoscopic cholecystectomy (LC) under general anesthesia

    Assessed in microgram

    Measured: The first six hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2026
  2. Study start15 Oct 2026 (estimated)
  3. Primary completion15 Oct 2028 (estimated)
  4. Study completion15 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07750769
Sponsor's protocol ID
SM82026
Status last verified
Aug 2026
First submitted
2 Aug 2026
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing EOI with OFA and OFA in people with Analgesia After Laparoscopic Cholecystectomy, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seham M Moeen, M.D. (01006386324 ext. 02, seham.moeen@aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the amount of fentanyl consumption used for pain relief in the first six hours after laparoscopic cholecystectomy (LC) under general anesthesia (time frame: The first six hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in